Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancer

Abstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer lacking effective drugs and therefore new treatment targets are needed. In this study, we define the role of homeobox protein B6 (HOXB6) and HOXB8 in controlling pancreatic cancer tumorigenesis and immune response. Transcriptomic an...

Full description

Saved in:
Bibliographic Details
Main Authors: Ludivine Bertonnier-Brouty, Sara Bsharat, Kavya Achanta, Jonas Andersson, Thanya Pranomphon, Tania Singh, Tuomas Kaprio, Jaana Hagström, Caj Haglund, Hanna Seppänen, Rashmi B. Prasad, Isabella Artner
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Molecular Biomedicine
Subjects:
Online Access:https://doi.org/10.1186/s43556-025-00292-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849344501531803648
author Ludivine Bertonnier-Brouty
Sara Bsharat
Kavya Achanta
Jonas Andersson
Thanya Pranomphon
Tania Singh
Tuomas Kaprio
Jaana Hagström
Caj Haglund
Hanna Seppänen
Rashmi B. Prasad
Isabella Artner
author_facet Ludivine Bertonnier-Brouty
Sara Bsharat
Kavya Achanta
Jonas Andersson
Thanya Pranomphon
Tania Singh
Tuomas Kaprio
Jaana Hagström
Caj Haglund
Hanna Seppänen
Rashmi B. Prasad
Isabella Artner
author_sort Ludivine Bertonnier-Brouty
collection DOAJ
description Abstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer lacking effective drugs and therefore new treatment targets are needed. In this study, we define the role of homeobox protein B6 (HOXB6) and HOXB8 in controlling pancreatic cancer tumorigenesis and immune response. Transcriptomic analysis comparing human embryonic and PDAC tissue identified a large overlap of expression profiles suggesting a re-initiation of developmental programs in pancreatic cancer. Specifically, we identified the transcription factors HOXB6 and HOXB8 as potential regulators in PDAC. We described their functions in pancreatic cancer by performing transcriptomic and tumor tissue microarray analyses, in vitro assays in pancreatic and lung cancer cell lines and co-culture experiments with immune cells. Loss of HOXB6 and HOXB8 in pancreatic cancer cells inhibited cell proliferation, induced apoptosis and senescence and enhanced gemcitabine sensitivity. Moreover, reduced HOXB6 and HOXB8 expression in pancreatic and lung adenocarcinoma cell lines affected transcription of immune response pathways which resulted in an increased sensitivity of cancer cells to anti-tumorigenic activities of macrophages suggesting that the HOXB6 and HOXB8 immune regulatory function is conserved in different cancer types. Additionally, naïve M0 macrophages exposed to HOXB8 deficient PDAC cells were unable to differentiate into tumor-associated macrophages, suggesting that HOXB8 promotes the transition of initial anti-tumor macrophage to a tumor-promoting macrophage phenotype in pancreatic cancer. Our findings indicate that HOXB6 and HOXB8 play important roles in regulating cell proliferation, immune response, and treatment resistance to promote pancreatic cancer tumorigenesis and could be useful therapeutic targets.
format Article
id doaj-art-988618689fa74bc8b6e687ffae8f2e73
institution Kabale University
issn 2662-8651
language English
publishDate 2025-07-01
publisher Springer
record_format Article
series Molecular Biomedicine
spelling doaj-art-988618689fa74bc8b6e687ffae8f2e732025-08-20T03:42:39ZengSpringerMolecular Biomedicine2662-86512025-07-016111810.1186/s43556-025-00292-5Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancerLudivine Bertonnier-Brouty0Sara Bsharat1Kavya Achanta2Jonas Andersson3Thanya Pranomphon4Tania Singh5Tuomas Kaprio6Jaana Hagström7Caj Haglund8Hanna Seppänen9Rashmi B. Prasad10Isabella Artner11Lund Stem Cell Center, Lund UniversityLund Stem Cell Center, Lund UniversityLund Stem Cell Center, Lund UniversityLund University Diabetes Center, Lund UniversityLund Stem Cell Center, Lund UniversityLund Stem Cell Center, Lund UniversityDepartment of Surgery, Helsinki University HospitalDepartment of Surgery, Helsinki University HospitalDepartment of Surgery, Helsinki University HospitalDepartment of Surgery, Helsinki University HospitalLund University Diabetes Center, Lund UniversityLund Stem Cell Center, Lund UniversityAbstract Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer lacking effective drugs and therefore new treatment targets are needed. In this study, we define the role of homeobox protein B6 (HOXB6) and HOXB8 in controlling pancreatic cancer tumorigenesis and immune response. Transcriptomic analysis comparing human embryonic and PDAC tissue identified a large overlap of expression profiles suggesting a re-initiation of developmental programs in pancreatic cancer. Specifically, we identified the transcription factors HOXB6 and HOXB8 as potential regulators in PDAC. We described their functions in pancreatic cancer by performing transcriptomic and tumor tissue microarray analyses, in vitro assays in pancreatic and lung cancer cell lines and co-culture experiments with immune cells. Loss of HOXB6 and HOXB8 in pancreatic cancer cells inhibited cell proliferation, induced apoptosis and senescence and enhanced gemcitabine sensitivity. Moreover, reduced HOXB6 and HOXB8 expression in pancreatic and lung adenocarcinoma cell lines affected transcription of immune response pathways which resulted in an increased sensitivity of cancer cells to anti-tumorigenic activities of macrophages suggesting that the HOXB6 and HOXB8 immune regulatory function is conserved in different cancer types. Additionally, naïve M0 macrophages exposed to HOXB8 deficient PDAC cells were unable to differentiate into tumor-associated macrophages, suggesting that HOXB8 promotes the transition of initial anti-tumor macrophage to a tumor-promoting macrophage phenotype in pancreatic cancer. Our findings indicate that HOXB6 and HOXB8 play important roles in regulating cell proliferation, immune response, and treatment resistance to promote pancreatic cancer tumorigenesis and could be useful therapeutic targets.https://doi.org/10.1186/s43556-025-00292-5Homeobox protein B6 (HOXB6)Homeobox protein B8 (HOXB8)Fetal pancreasPancreatic cancerPancreatic ductal adenocarcinomaTumor-associated-macrophages
spellingShingle Ludivine Bertonnier-Brouty
Sara Bsharat
Kavya Achanta
Jonas Andersson
Thanya Pranomphon
Tania Singh
Tuomas Kaprio
Jaana Hagström
Caj Haglund
Hanna Seppänen
Rashmi B. Prasad
Isabella Artner
Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancer
Molecular Biomedicine
Homeobox protein B6 (HOXB6)
Homeobox protein B8 (HOXB8)
Fetal pancreas
Pancreatic cancer
Pancreatic ductal adenocarcinoma
Tumor-associated-macrophages
title Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancer
title_full Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancer
title_fullStr Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancer
title_full_unstemmed Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancer
title_short Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancer
title_sort homeobox protein b6 and homeobox protein b8 control immune cancer cell interactions in pancreatic cancer
topic Homeobox protein B6 (HOXB6)
Homeobox protein B8 (HOXB8)
Fetal pancreas
Pancreatic cancer
Pancreatic ductal adenocarcinoma
Tumor-associated-macrophages
url https://doi.org/10.1186/s43556-025-00292-5
work_keys_str_mv AT ludivinebertonnierbrouty homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT sarabsharat homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT kavyaachanta homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT jonasandersson homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT thanyapranomphon homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT taniasingh homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT tuomaskaprio homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT jaanahagstrom homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT cajhaglund homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT hannaseppanen homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT rashmibprasad homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer
AT isabellaartner homeoboxproteinb6andhomeoboxproteinb8controlimmunecancercellinteractionsinpancreaticcancer